Search results

MAGMA has it for download under the reference section for European: https://cncr.nl/research/magma/ I have no idea if it's the same format as what you'd need for the finemapping part.

Yeah, I'm not sure of the size. Maybe that's raw individual data while all you'd need is more of a summary format. It just seemed like you might need to apply as a researcher to get access to UKB data. But it's possible there's some source out there we didn't see.

Posts about a drug trial in the STIMULATE-ICP project have been moved to: STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured...

Here's the abstract: STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocol [Line breaks added] Introduction Long...

I made a thread to dicuss this other paper: Connecting the Dots Between ME/CFS, HSD/hEDS, Abnormal Fascia, Lymphatic and Glymphatic System Impairment, and Craniocervical Instability, 2025, Lubel

Some posts have been moved to: Evidence that M.E. isn’t contagious?

Connecting the Dots Between ME/CFS, HSD/hEDS, Abnormal Fascia, Lymphatic and Glymphatic System Impairment, and Craniocervical Instability Lubell, Jeffrey Abstract This hypothesis paper encourages a comprehensive approach to studying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)...

Thanks @Nightsong. If anyone's interested, here's a 51 minute talk from Emma Wall from earlier this year:

See post #8 for abstract -------- Nature Medicine: "Eleven clinical trials that will shape medicine in 2026" "Nature Medicine asks leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers and long...

BioBank would be ideal, since it more closely matches the participants. But 1000G still worked well enough to get relatively the same results when I used it in FUMA the first time, mostly just less significant. I don't think @hotblack and I ended up finding a source for UKB LD files when trying...

I don't think I tried fine mapping at all. That's about where I gave up trying to do FLAMES. (Edit: I don't think I did pops either actually.)

The link still seems to work for me. This came up in Google Scholar alerts and can be seen in search results, but it links to the same thing.

Interesting and refreshingly self-aware. Some patients. But other forums are filled with people who think the treatment is in the next supplement. Or people who don't read about ME/CFS every day like us. They got sick, the doctor says there's a name for it, and they expect the doctor to do...

Oh great, yeah I think I sent the wrong URL.

Broadly neutralizing antibodies to SARS-CoV-2 in Long COVID are associated with viral persistence and clinical outcome Chenyu Liu, Daniel Sanson, Serhan Soylu, Leen Moens, Isabelle Meyts, Marc Jamoulle, Johan Van Weyenbergh [Line breaks added] Abstract Long COVID (also known as post-acute...

Desentangling the Long Covid biomarker network: Insights into viral persistence and therapeutic response using random forest feature selection Daniel Sanson , Chenyu Liu, Serhan Soylu, Leen Moens, Isabelle Meyts, Marc Jamoulle, Johan Van Weyenbergh [Line breaks added] Abstract Long COVID...

Sure, it was private before, but it's public now: https://fuma.ctglab.nl/snp2gene/653365

Heightened prevalence of chronic fatigue syndrome in U.S. sexual minorities Purpose To assess the prevalence and odds of chronic fatigue syndrome (CFS) among lesbian, gay, bisexual, and other sexual minority individuals (LGB+) in the United States using a multi-year, nationally representative...

Sure. It's too big to upload here, but I uploaded it to a file sharing site. The link will expire in a week: https://limewire.com/d/gyXn2#CsV6DOeqGh The link isn't working for me. I think something was different. @ME/CFS Science Blog pointed out that there seemed to be fewer variants than...

Could it be that 58.3% refers to the proportion of people with hypertension when only considering people with at least one comorbidity?